Health Products

Sanofi Consumer Health Zantac Product Recall (2019-10-18)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I

Summary

Product

Zantac 75 mg Tablet;

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
All lots
Recalling Firm
Sanofi Consumer Health Inc.
B.  Zantac 150 mg TabletDIN 02277301TabletRanitidine 150 mg
All lots
Recalling Firm
Sanofi Consumer Health Inc.
A.  Zantac 75 mg TabletDIN 02230287TabletRanitidine 75 mg

Introduction

  1. Zantac 75 mg Tablet;
  2. Zantac 150 mg Tablet

Reason

Affected lots may be manufactured with an API containing an impurity, N-nitrosodimethylamine (NDMA).

Depth of distribution

Wholesalers, Healthcare Establishments, Retailers

Related alerts

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime